GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Energenesis Biomedical Co Ltd (TPE:6657) » Definitions » Dividends Received

Energenesis Biomedical Co (TPE:6657) Dividends Received


View and export this data going back to 2018. Start your Free Trial

What is Energenesis Biomedical Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.


Energenesis Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Lane 583, Ruiguang Road, 6th Floor -3, Neihu District, Taipei, TWN, 11492
Energenesis Biomedical Co Ltd is a biomedicine company. It is engaged in businesses related to biological experimentation and analysis, as well as new drug development. The company uses its ENERGI drug development platform to activate AMP-activated protein kinase (AMPK), a key enzyme in cell energy regulation, as a means of developing disease treatments. Its product pipeline consists of ENERGI-F703, a diabetic foot ulcers treatment gel; ENERGI-F701, a product developed for male hair loss; ENERGI-F704, an inflammatory bowel disease treatment; and ENERGI-F711, a burn cream, among others.